Health evaluation of free-ranging guanaco (Lama guanicoe).
Twenty free-ranging guanaco (Lama guanicoe) in Chubut Province, Argentina, were immobilized for health evaluations. All but two animals appeared to be in good condition. Hematology, serum chemistry, and vitamin and mineral levels were measured, and feces were evaluated for parasites. Serology tests included bluetongue, brucellosis, bovine respiratory syncitial virus, bovine viral diarrhea/mucosal disease, equine herpesvirus 1, infectious bovine rhinotracheitis, Johne's disease (Mycobacterium paratuberculosis), foot and mouth disease, leptospirosis (17 serovars), parainfluenza-3, and vesicular stomatitis. Blood samples from 20 domestic sheep (Ovis aries) maintained in the same reserve with the guanaco were also collected at the same time for serology tests. No guanaco had positive serologic tests. Sheep were found to have antibody titers to bovine respiratory syncytial virus, Johne's disease, leptospirosis, and parainfluenza-3. There was no apparent difference in external appearance or condition, or statistical difference in blood test values, between the animals that were positive or negative for parasite ova.
Karesh
W B
WB
Wildlife Conservation Society, Bronx, New York 10460, USA.
Uhart
M M
MM
Dierenfeld
E S
ES
Braselton
W E
WE
Torres
A
A
House
C
C
Puche
H
H
Cook
R A
RA
D000701:Analgesics, Opioid / Q000037:antagonists & inhibitors; D000777:Anesthetics / Q000037:antagonists & inhibitors; D000818:Animals; D000829:Animals, Domestic / Q000097:blood / Q000276:immunology / Q000502:physiology; D000835:Animals, Wild / Q000097:blood / Q000276:immunology / Q000502:physiology*; D000906:Antibodies / Q000097:blood; D000931:Antidotes / Q000494:pharmacology; D001774:Blood Chemical Analysis / Q000662:veterinary; D002161:Camelids, New World / Q000097:blood / Q000276:immunology / Q000502:physiology*; D003141:Communicable Diseases / Q000175:diagnosis / Q000276:immunology / Q000662:veterinary; D004338:Drug Combinations; D004798:Enzymes / Q000097:blood; D005260:Female; D005283:Fentanyl / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors; D005442:Flumazenil / Q000494:pharmacology; D006304:Health Status; D007103:Immobilization; D008297:Male; D008903:Minerals / Q000097:blood; D009271:Naltrexone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D010808:Physical Examination / Q000662:veterinary; D012016:Reference Values; D012756:Sheep / Q000097:blood / Q000276:immunology / Q000502:physiology; D013992:Tiletamine / Q000037:antagonists & inhibitors; D014815:Vitamins / Q000097:blood; D015041:Zolazepam / Q000037:antagonists & inhibitors
D000701:Analgesics, Opioid; D000777:Anesthetics; D000906:Antibodies; D000931:Antidotes; D004338:Drug Combinations; D004798:Enzymes; D008903:Minerals; D009292:Narcotic Antagonists; D014815:Vitamins; C006131:tiletamine, zolazepam drug combination; D013992:Tiletamine; D005442:Flumazenil; D009271:Naltrexone; D015041:Zolazepam; C017114:carfentanil; D005283:Fentanyl